Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis

The Journal of Rheumatology
Yasushi MatsuyamaSeiji Minota

Abstract

To determine levels of interleukin 33 (IL-33) in serum and synovial fluid (SF) and their clinical associations in patients with rheumatoid arthritis (RA). To evaluate the ability of activated peripheral blood mononuclear cells (PBMC) and fibroblast-like synoviocytes (FLS) from RA patients to release IL-33. Sera were obtained from 59 patients with RA, 10 patients with infectious diseases, and 42 healthy volunteers. SF samples were obtained from 15 patients with RA and 13 with osteoarthritis. IL-33 levels were measured using a sandwich ELISA after removal of rheumatoid factor with protein A-Sepharose beads. FLS were stimulated with IL-1beta and tumor necrosis factor, and treated with or without chemical damage. PBMC were stimulated with anti-CD3/CD28 antibodies. The levels of IL-33 were measured in the culture supernatants and cell lysates by ELISA or immunoblotting. Serum IL-33 levels were significantly higher in RA patients, especially in the high disease activity group compared to the moderate or low activity group. IL-33 levels in SF were elevated in all 15 RA patients measured. IL-33 levels were higher in SF samples than in sera in 7 RA patients measured simultaneously. The 30-kDa IL-33 precursor was detected in the culture ...Continue Reading

References

Dec 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Virginie CarriereJean-Philippe Girard
Jul 12, 2007·The Journal of Biological Chemistry·Hiroko HayakawaShin-ichi Tominaga
Aug 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zoulfia AllakhverdiGuy Delespesse
Nov 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Shafaqat AliMichael U Martin
Jun 10, 2008·The Journal of Allergy and Clinical Immunology·W Brett CherryHirohito Kita
Jul 8, 2008·Cellular Signalling·Megumi Funakoshi-TagoTadashi Kasahara
Aug 1, 2008·Proceedings of the National Academy of Sciences of the United States of America·Damo XuFoo Y Liew
Feb 28, 2009·Arthritis and Rheumatism·Gaby PalmerCem Gabay
May 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·Corinne Cayrol, Jean-Philippe Girard
May 26, 2009·The Journal of Biological Chemistry·Dominique Talabot-AyerGaby Palmer
Jun 30, 2009·Immunity·Alexander U LüthiSeamus J Martin
Jul 15, 2009·Biochemical and Biophysical Research Communications·Morisada HayakawaShin-ichi Tominaga

❮ Previous
Next ❯

Citations

Jun 27, 2013·Human Immunology·Wang-Dong XuDong-Qing Ye
Mar 23, 2010·Cellular & Molecular Immunology·Weihua Zhao, Zhiqing Hu
May 27, 2011·Mucosal Immunology·J B SeidelinO H Nielsen
Jan 31, 2013·Rheumatology·Neal L MillarIain B McInnes
Oct 16, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Andrea CaporaliCostanza Emanueli
Mar 29, 2012·Circulation. Heart Failure·Eric D AbstonDeLisa Fairweather
Apr 16, 2013·The Journal of Clinical Investigation·Melissa Y TjotaAnne I Sperling
Aug 30, 2011·Journal of Inflammation·Ashley M Miller
Jan 18, 2013·Arthritis Research & Therapy·Praxedis MartinGaby Palmer
Oct 27, 2011·PloS One·Christian D SadikAndrew D Luster
Sep 29, 2011·Journal of the American Society of Nephrology : JASN·Ali AkcayCharles L Edelstein
Jan 17, 2012·International Journal of Molecular Medicine·Elke KunischRaimund W Kinne
Oct 24, 2013·Clinical & Developmental Immunology·Lihua DuanGuixiu Shi
May 2, 2014·Arthritis Research & Therapy·Chun LiZhanguo Li
Jul 16, 2014·Cytokine·Dominique Talabot-AyerGaby Palmer
Oct 5, 2011·Clinical Rheumatology·Guo-Wei HanShao-Yu Liu
May 16, 2015·Clinical and Experimental Dermatology·A MitsuiY Asano
Oct 15, 2013·Immunology·Cheng PeiHui-Rong Jiang
May 29, 2012·Pulmonary Pharmacology & Therapeutics·Yuxiu C XiaRachel L Clifford
Jun 8, 2012·The Journal of Investigative Dermatology·Jitlada MeephansanMamitaro Ohtsuki
Jul 18, 2014·BioMed Research International·Qing Zhao, Guangjie Chen
Dec 17, 2010·Journal of Internal Medicine·M Kurowska-StolarskaI B McInnes
Jul 23, 2015·Ageing Research Reviews·Ramar Perumal Samy, Lina H K Lim
Oct 2, 2015·Clinical and Translational Allergy·Rohit SalujaMarcus Maurer
Sep 15, 2015·Nature Communications·E Suzanne CohenTomas Mustelin
May 4, 2016·Clinical Pharmacology in Drug Development·Jessica C LeeNiranjan Y Sardesai
Mar 31, 2011·Expert Opinion on Therapeutic Targets·Feng-Lai YuanJian Dong
Sep 24, 2013·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·A Beklen, G Tsaous Memet
Apr 24, 2010·Allergology International : Official Journal of the Japanese Society of Allergology·Keisuke ObokiSusumu Nakae
Nov 25, 2014·Cellular and Molecular Neurobiology·Li-Tian HuangChun-Hua Hang
Aug 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yasutomo ImaiKiyofumi Yamanishi
Aug 15, 2014·Rheumatology International·Suleyman Serdar KocaAhmet Isik
Oct 4, 2016·Revista Brasileira De Reumatologia·Rafaela Bicalho Viana MacedoMarcus Vinicius Melo de Andrade
Jun 19, 2016·Arthritis Research & Therapy·Sara Khaleghparast AthariNatacha Bessis
Aug 30, 2016·Cellular & Molecular Immunology·Damien Bertheloot, Eicke Latz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.